Dr. Karim Dabbagh to Present at GTCbios 3rd Protein Kinase in Drug Discovery Conference on May 5-6
Summary
Press Releases GTCbio Press Release Receive press releases from GTCbio: By Email RSS Feeds: Dr. Karim Dabbagh to Present at GTCbios 3rd Protein Kinase in Drug Discovery Conference on May 5-6 Dr. Karim Dabbagh the Director of Pharmacology at Hoffmann-La Roche will present at GTCbios 3rd Protein Kinase in Drug Discovery Conference on May 5-6, 2008 in San Diego, CA.Their goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com ### Monrovia, CA, March 30, 2008 --( PR.com )-- Dr. Dabbagh’s presentation will cover P38 MAP Kinases and the important roles they play in inflammatory responses.The clinical applications of these inhibitors will also be discussed.GTCbio’s 3rd Protein Kinase in Drug Discovery Conference will take place on May 5-6, 2008 in San Diego, CA and will cover Kinase Drug Design, Kinase Targets and Inhibitors in CNS Disorders, Oncology, and Inflammatory Disorders, as well as New Technologies in Screening and Identifying Targets and Inhibitors.The conference also features presentations from other leading organizations such as Johnson & Johnson, Roche, Pfizer, Merck, GlaxoSmithKline, Salk Institute, AstraZeneca, Methylgene, UCSD, and many more.For more information including a detailed agenda, exhibitor opportunities and registration information call 626-256-6405 or visit them at gtcbio.comAbout GTCbioGTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries.